Predict your next investment

HEALTHCARE | Biotechnology
nucien.com

See what CB Insights has to offer

Stage

IPO | IPO

Total Raised

$19.77M

Date of IPO

3/26/2020

About Nucien

Developer of anti infectious drugs, cardiovascular drugs, and anti cancer drugs.

Nucien Headquarter Location

1 Kangli Road

Changsha, Hunan, 510530,

China

86 20 38952013

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Nucien

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nucien is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,880 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.